Pages that link to "Q33761790"

The following pages link to Dyskinesias after neural transplantation in Parkinson's disease: what do we know and what is next? (Q33761790):

Displaying 25 items.

• Foetal Cell Transplantation for Parkinson's Disease: Focus on Graft-Induced Dyskinesia (Q26765499) (← links)
• Drug-induced dyskinesia in Parkinson's disease. Should success in clinical management be a function of improvement of motor repertoire rather than amplitude of dyskinesia? (Q27021464) (← links)
• Treating Parkinson's disease in the 21st century: can stem cell transplantation compete? (Q27024152) (← links)
• Sox-2 Positive Neural Progenitors in the Primate Striatum Undergo Dynamic Changes after Dopamine Denervation (Q27314710) (← links)
• Cell fate analysis of embryonic ventral mesencephalic grafts in the 6-OHDA model of Parkinson's disease (Q27334576) (← links)
• Neuroimaging in Parkinson disease: from research setting to clinical practice (Q30868628) (← links)
• Optimizing functional imaging protocols for assessing the outcome of fetal cell transplantation in Parkinson's disease (Q33898436) (← links)
• Clinical application of stem cell therapy in Parkinson's disease (Q34118131) (← links)
• Prospect of cell therapy for Parkinson's disease (Q34131282) (← links)
• Treating non-motor symptoms of Parkinson's disease with transplantation of stem cells (Q36790753) (← links)
• Serotonergic mechanisms responsible for levodopa-induced dyskinesias in Parkinson's disease patients (Q37602233) (← links)
• Neurotransplantation: lux et veritas, fiction or reality? (Q37971309) (← links)
• Positron emission tomography imaging in neurological disorders (Q37980609) (← links)
• Pluripotent stem cells for Parkinson's disease: progress and challenges (Q38106771) (← links)
• Dyskinesias in Parkinson's disease: views from positron emission tomography studies (Q38182651) (← links)
• Molecular imaging of levodopa-induced dyskinesias. (Q38355582) (← links)
• Serotonin transporter in Parkinson's disease: A meta-analysis of positron emission tomography studies (Q39055550) (← links)
• Serotonin neuron loss and nonmotor symptoms continue in Parkinson's patients treated with dopamine grafts (Q39249440) (← links)
• PET Molecular Imaging Research of Levodopa-Induced Dyskinesias in Parkinson's Disease (Q42369736) (← links)
• Graft-induced dyskinesias fail to respond to 5HT1A agonist in the long-term (Q48287510) (← links)
• The serotonergic system in Parkinson's patients with dyskinesia: evidence from imaging studies (Q48372783) (← links)
• Imaging Markers of Progression in Parkinson's Disease (Q64785657) (← links)
• Discovery of Novel Cell Surface Markers for Purification of Embryonic Dopamine Progenitors for Transplantation in Parkinson's Disease Animal Models (Q64869052) (← links)
• Stem cells and regenerative therapies for Parkinson's disease. (Q64993682) (← links)
• Stimulation of L-type calcium channels increases tyrosine hydroxylase and dopamine in ventral midbrain cells induced from somatic cells (Q90184036) (← links)